Cycrin (Medroxyprogesterone) – Patient Information (Australia)

Cycrin contains medroxyprogesterone, a hormone medicine used for a variety of gynaecological and hormone-related conditions. This page explains how Cycrin works, how it is used, what to expect, and important safety considerations for people in Australia.

Always follow the instructions provided by your healthcare professional and the directions on your medicine label. If you are unsure about any detail, ask a pharmacist.

Quick overview

• Active ingredient: Medroxyprogesterone
• Medicine type: Progestogen (synthetic progesterone)
• Common forms: Tablets (strengths vary by product)
• Common reasons for use: Hormone-related management of the womb lining (endometrium), and certain cycle/bleeding-related indications
• Key safety points: Blood clots, liver issues, abnormal vaginal bleeding, and pregnancy risk (do not use if pregnant)

Basic product information

How Cycrin works (mechanism of action)

Medroxyprogesterone is a progestogen. It mimics the actions of the body’s natural hormone progesterone. In the womb (uterus), progesterone helps control how the inner lining grows and sheds.

• Stabilises the endometrium: It helps regulate thickening and shedding of the uterine lining.
• Reduces uncontrolled growth: Progestogens can help counter the effects of oestrogen on the endometrium.
• Influences bleeding patterns: By changing hormonal signalling, it can lead to predictable bleeding or reduced irregular bleeding in some settings.
• Systemic hormonal effects: It affects reproductive hormone feedback loops, which can alter menstrual cycle patterns.

Pharmacokinetics: absorption, distribution, metabolism, and excretion

“Pharmacokinetics” describes what the body does to the medicine (and how the medicine moves through the body).

• Absorption: Medroxyprogesterone is absorbed after oral administration. Peak levels typically occur within a few hours, though timing can vary between individuals.
• Distribution: It binds to proteins in the blood and is distributed throughout body tissues.
• Metabolism: It is primarily metabolised by the liver.
• Excretion: Metabolites are eliminated mainly through urine and faeces.

Because the medicine is metabolised in the liver, liver function may be considered when deciding on suitability and dosing.

Typical uses of Cycrin

Cycrin may be used for hormone-related conditions. The exact indication and dosing regimen depend on your situation, including age, medical history, and the reason your clinician recommended it.

Common indications include (as applicable to local prescribing practices and individual assessment):

• Management of abnormal uterine bleeding related to hormone imbalance
• Endometrial protection in certain hormonal therapy situations (where progestogen is needed to reduce risk associated with unopposed oestrogen)
• Conditions involving endometrial overgrowth where progestogen therapy is appropriate
• Some reproductive hormone-related treatments under specialist guidance

If you’re using Cycrin for a specific diagnosis, ask your pharmacist or clinician to clarify what your treatment aims to achieve (for example: regulating bleeding, reducing endometrial changes, or preventing further abnormal lining growth).

Timing and how to take Cycrin

Cycrin is taken by mouth. The dose and timing depend on the reason you’re taking it. Schedules can be continuous or cyclical.

General timing guidance

• Choose a consistent time: Take your tablet at the same time each day to maintain steady levels and improve adherence.
• Follow the schedule exactly: Some uses require taking Cycrin for a set number of days per cycle; others require daily dosing.
• If you miss a dose: Take it when you remember unless it’s close to the next dose. Do not double up unless advised.

If you’re unsure about what to do after missing a dose, check the consumer medicines information (CMI) and your label instructions, or ask a pharmacist.

Food interactions

For many people, Cycrin can be taken with or without food. However, individual tolerance may vary.

• Stomach comfort: If you experience nausea, taking it with a meal or snack may help.
• Medication consistency: Keep your routine steady so your dosing experience remains predictable.

If you are taking other medicines as well (including herbal products), ask your pharmacist about interactions, because food is only one factor—other medicines may affect liver metabolism.

Alcohol and medicine interactions

Alcohol may affect how you feel on hormonal therapy and may contribute to side effects such as dizziness or nausea in some people.

• General caution: Keep alcohol intake moderate and note how your body responds.
• Liver considerations: Both alcohol and hormones are processed through the body; heavy alcohol use may increase strain on the liver.
• Medication safety: Avoid binge drinking, especially if you have liver disease or a history of medication-related liver problems.

There are no specific “prohibited” alcohol rules for every patient, but your personal risk profile matters. If you have questions, discuss alcohol use with your clinician or pharmacist.

Medicine interactions (key points)

Several medicines can change medroxyprogesterone levels or increase side effects by affecting liver enzymes or hormone-related processes.

• Enzyme inducers: Medicines that strongly activate liver enzymes may reduce hormone levels, potentially making treatment less effective.
• Some anti-epileptics: Certain seizure medicines can affect hormone metabolism.
• St John’s wort: Herbal products containing St John’s wort may reduce effectiveness by increasing metabolism.
• Anticoagulants/antiplatelets: Progestogens can affect clotting risk; your overall clotting risk and medication plan should be reviewed carefully.
• Diabetes medicines: Hormonal changes can sometimes affect glucose control in some people.

Important: This is not a complete list. Tell your pharmacist about all medicines and supplements you take (including vitamins, herbal remedies, and over-the-counter products).

Dosing information (overview)

Dosing for Cycrin depends on the indication, your age, bleeding pattern, and your clinician’s assessment. There is no single “universal” schedule.

Common regimen patterns (examples of how schedules may be structured in clinical practice) include:

• Cyclical dosing: Taken for a number of days each month or cycle, followed by days without the medicine.
• Continuous dosing: Taken once daily with no scheduled breaks, depending on the condition.

Your label and CMI should specify the exact dose and days to take Cycrin for your situation. Do not change your dose without medical advice.

Duration of treatment

• Some people use Cycrin for a short course to manage a specific issue.
• Others may need longer therapy, with periodic review of symptoms and response.

Indications in more detail: what Cycrin is used for

The following descriptions are general. Your clinician may tailor treatment based on test results and examination findings.

• Abnormal uterine bleeding (hormone-related):

  Progestogens can help stabilise the uterine lining, supporting more predictable shedding and reducing irregular or heavy bleeding in selected cases.

• Endometrial protection (in appropriate hormonal therapy):

  In certain situations where oestrogen may stimulate the endometrium, a progestogen helps reduce the risk of abnormal overgrowth.

• Endometrial changes/overgrowth:

  Progestogen therapy may be used to treat or manage conditions involving abnormal thickening or precancerous changes, under specialist supervision.

If bleeding changes occur while you’re using Cycrin—especially new or worsening bleeding—contact your healthcare professional for review.

Safety profile: who should be cautious

Cycrin can be helpful, but it is not suitable for everyone. Safety decisions depend on your medical history and current risk factors.

Do not take (or use with extra caution) if you have certain conditions

Contraindications can include, but are not limited to, situations such as:

• Pregnancy: Cycrin is not intended to be taken during pregnancy.
• Known or suspected breast cancer or other hormone-sensitive cancers (individual assessment required).
• Severe liver disease or active liver problems.
• Unexplained vaginal bleeding that has not been evaluated.
• History of blood clots (for example, deep vein thrombosis or pulmonary embolism) or certain clotting risk factors (discuss with your clinician).

If you’re unsure whether any of these apply to you, speak with a pharmacist or clinician.

Important warnings and possible serious side effects

• Blood clots: Seek urgent medical attention if you develop symptoms of a clot such as:
  • Sudden shortness of breath
  • Chest pain
  • Coughing blood
  • One-sided leg swelling or pain
  • Sudden severe headache, weakness, or speech problems
• Liver problems: Contact your doctor urgently if you notice yellowing of the skin/eyes (jaundice), dark urine, or severe abdominal pain.
• Severe or persistent abnormal bleeding: New heavy bleeding, bleeding after long gaps, or bleeding after treatment is expected to have controlled symptoms should be assessed.
• Mood changes: Some people report mood changes, including depression or irritability. Seek advice if symptoms are significant.

Common side effects

Side effects vary by dose and individual susceptibility. Commonly reported effects may include:

• Nausea or stomach discomfort
• Headache
• Bloating or fluid retention
• Breast tenderness
• Changes in menstrual bleeding patterns (spotting, breakthrough bleeding, amenorrhoea)
• Changes in mood or libido
• Weight changes (in some people)

If side effects are bothersome or do not settle, discuss them with your pharmacist or clinician.

Practical use tips

• Use a reminder: Set a phone alarm or calendar reminder for consistent dosing.
• Track bleeding and symptoms: Keep a short diary of bleeding days, severity, and any side effects. This can help your clinician assess effectiveness and safety.
• Don’t stop suddenly without advice: If you stop Cycrin unexpectedly, bleeding patterns may change and the treatment goal may not be met.
• Report new symptoms promptly: Especially symptoms suggestive of blood clots, severe headaches, or unusual bleeding.
• Know your risk factors: If you smoke, have migraine with aura, obesity, a history of clots, or a strong family history of clots, discuss this with your clinician.

Monitoring and follow-up

Depending on why you’re taking Cycrin, your clinician may monitor your response through:

• Review of bleeding pattern and symptoms
• Physical examinations when needed
• Ultrasound or other investigations if abnormal bleeding continues
• Regular review to decide whether to continue, adjust, or stop treatment

If you have persistent abnormal bleeding or symptoms that worry you, don’t wait for the next routine appointment.

Alternative options

Alternatives depend on the indication for Cycrin. Your clinician may consider other progestogens or other strategies based on your diagnosis, age, and risk profile.

Possible alternatives may include:

• Other progestogen medicines (different dose forms and schedules)
• Progesterone-containing regimens where appropriate
• Non-hormonal options for symptom control in selected cases
• In some situations, procedures (depending on the underlying cause of bleeding)

For the best guidance, ask your pharmacist or clinician what alternatives are suitable for your condition and why.

Market and legal context for Australia

In Australia, prescription medicines are regulated to ensure safe supply and appropriate patient counselling. Availability can depend on product listing and pharmacy supply arrangements.

Cycrin is an established medicine with continued clinical use in appropriate cases. Online pharmacies may require patient information verification and professional review processes in line with Australian regulations and pharmacy policies.

If you have questions about availability in your area or about the product you’re ordering, contact the online pharmacy’s support team before purchase.

Recent guidance and updates (general patient perspective)

Guidance for hormonal therapies and abnormal bleeding management can evolve as new evidence emerges. Key areas clinicians typically review include:

• Risk–benefit assessment for clotting and cardiovascular risk
• Appropriate evaluation of abnormal uterine bleeding to rule out serious causes
• Monitoring of liver health when relevant
• Individualised dosing according to indication and response

To stay up to date, your pharmacist can share the consumer medicines information and advise on any practical changes relevant to your regimen.

Delivery and availability (Australia)

Online pharmacies may deliver Cycrin to eligible locations within Australia. Availability can vary by stock levels and the specific tablet strength.

• Dispatch times: Vary by supplier and stock status.
• Packaging: Medicines are typically supplied in original manufacturer packaging.
• Cold-chain: Not usually required for tablet medicines unless specifically stated.
• Order accuracy: Check the strength, name, and dosing instructions on arrival.

If you receive an item that doesn’t match what you expected (for example, different strength), contact the pharmacy immediately rather than using it.

Frequently asked questions (FAQ)

1) What is Cycrin used for?

Cycrin (medroxyprogesterone) is used for hormone-related conditions, most commonly involving the womb lining and bleeding patterns. The specific reason depends on your diagnosis and treatment plan.

2) How long does it take to work?

Some people notice changes in bleeding within the first cycle or weeks. How quickly symptoms improve depends on the reason you’re taking it and your starting hormone levels. Your clinician can provide expectations for your specific indication.

3) Can I take Cycrin with food?

In most cases, it can be taken with or without food. If it upsets your stomach, taking it with a meal may improve tolerability.

4) What if I miss a dose?

If you miss a tablet, take it as soon as you remember unless it’s near the next dose. Do not double up unless your pharmacist or CMI instructs you to. If you’re unsure, ask your pharmacist.

5) Will Cycrin affect my menstrual period?

Yes. Cycrin can change bleeding patterns, including spotting or changes in the timing and amount of periods. Some people may stop having periods during treatment. If bleeding becomes very heavy or unusual for you, get medical advice.

6) Is it safe to drive or work while taking Cycrin?

Many people can drive and work normally. However, if you experience dizziness, unusual fatigue, or other side effects, avoid driving or operating machinery until you feel well.

7) Can I drink alcohol while taking Cycrin?

Moderate alcohol may be tolerated by many people, but alcohol can worsen nausea or dizziness and may add stress on the liver. If you have liver disease or notice side effects, limit alcohol and ask your clinician for personalised advice.

8) Are there medicines or supplements I should avoid?

Some medicines (and herbal products like St John’s wort) can affect hormone levels. Always share your medication list with your pharmacist to check for interactions.

9) What are the red-flag symptoms that require urgent help?

Seek urgent medical attention if you have symptoms that could indicate a blood clot (such as sudden shortness of breath, chest pain, one-sided leg swelling, or coughing blood), severe headache with neurological symptoms, or signs of liver problems (jaundice, dark urine, severe abdominal pain).

10) What should I do if I think I might be pregnant?

If pregnancy is possible, contact your healthcare provider promptly. Cycrin is not intended for use in pregnancy. Your clinician can advise on the next steps.

Final reminders

• Use Cycrin exactly as directed on your label and by your healthcare professional.
• Track bleeding and side effects—this improves follow-up and safety.
• Contact a healthcare professional promptly for new or severe symptoms, especially abnormal bleeding or signs of blood clots.

For personalised advice about your specific indication, dosing schedule, and safety risks, speak with your pharmacist or clinician.